Towards better diagnosis of neurodegenerative disorders: Skin biopsy for α-synuclein detection proves effective

FHS
March 26, 2024
10:20 am

The positivity rate of cutaneous phosphorylated alpha-synuclein protein (P-SYN) deposition among individuals with dementia.

Cannabis REIT Beats Expectations in Q2

Innovative Industrial Properties Reports Second Quarter 2023 Results SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New

August 3, 2023

Adding Regorafenib in First-Line ‘Promising’ in Gastric Cancer

Adding regorafenib (Stivarga) to a standard first-line chemoimmunotherapy regimen for HER2-negative metastatic esophagogastric cancer demonstrated “promising” activity in a single-arm phase II study, according to

September 6, 2023

Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio – Pharmaceutical Technology

Novartis will inherit Mariana’s lead asset MC-339, a radioligand therapy (RLT) designed to target small cell lung cancer. Credit: JHVEPhoto via Shutterstock. Novartis is firming

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.